ASX Share rice
Sat 15 Aug 2020 - 04:53:pm (Sydney)

RSH Share Price

RESPIRI LIMITEDRSHHealth Care Equipment & Services

RSH Company Information

Name:

Respiri Limited

Sector:

Healthcare

Industry:

Medical Devices

GIC Industry:

Health Care Equipment & Supplies

GIC Sub Industry:

Health Care Equipment

Address:

Suite 1 Melbourne Australia 3004

Phone:

61 3 9653 9160

Chief Research Officer:

Dr. Samaneh Sarraf Shirazi

Exec. Chairman:

Mr. Nicholas Smedley

CEO & Director:

Mr. Marjan Mikel B.Sc., M.A.I.C.D.

Vice-Pres of Bus. Devel.:

Ms. Jan P. Barker

Company Sec.:

Mr. Alastair Beard

Company Overview:

Respiri Limited, a health technology company, researches, develops, and commercializes, medical devices in Australia and Israel. The company produces and sells mobile health applications. Its products include Wheezo, a mobile app, which has asthma management diary, medication usage and reminders, and symptoms and triggers to help asthma sufferers; Wholter, a device for home ambulatory recording of nocturnal wheeze and cough; and AirSonea, a digital stethoscope that is paired to a smartphone app to record breathing sounds accurately. The company also offers PulmoTrack, a computerized wheeze detection product designed for hospital/clinical based real-time monitoring of wheeze and cough in the management of acute asthma in the ER and ICU, and for pediatric pulmonary function testing and sleep labs; and SonoSentry, an over-the-counter wheeze-detection device. The company was formerly known as iSonea Limited and changed its name to Respiri Limited in December 2015. Respiri Limited was incorporated in 1987 and is based in Melbourne, Australia.

RSH Share Price Information

Shares Issued:

652.84M

Market Capitalisation:

$94.66M

Revenue (TTM):

$2.16M

Revenue Per Share (TTM):

$0

Earnings per Share:

$-0.017

Operating Margin (TTM):

$-3.15

Return On Assets (TTM):

$-1.69

Return On Equity (TTM):

$-12.42

Quarterly Revenue Growth (YOY):

1.1

Gross Profit(TTM):

$1.03M

Diluted Earnings Per Share (TTM):

$-0.013

RSH CashFlow Statement

CashFlow Date:

2019-06-30

Investments:

$-3,179

Change To Liabilities:

$759.72K

Total Cashflow From Investing Activities:

$-3,179

Net Borrowings:

$800K

Net Income:

$-8,474,586

Total Cash From Operating Activities:

$-6,411,325

Depreciation:

$4.63K

Change To Account Receivables:

$-42,805

Sale Purchase Of Stock:

$-218,000

Capital Expenditures:

$3.18K

RSH Income Statement

Income Date:

2019-06-30

Income Before Tax:

$-8,474,586

Net Income:

$-8,474,586

Gross Profit:

$1.03M

Operating Income:

$-9,486,336

Total Revenue:

$1.03M

Total Operating Expenses:

$9.49M

RSH Balance Sheet

Balance Sheet Date:

2019-06-30

Total Liabilities:

$2.58M

Total Stockholder Equity:

$-1,562,704

Other Current Liabilities:

$12.91K

Total Assets:

$1.01M

Common Stock:

$106.04M

Other Current Assets:

$12.39K

Retained Earnings:

$-108,191,858

Other Assets:

$1.17K

Cash:

$306.66K

Total Current Liabilities:

$2.58M

Short-Term Debt:

$806.44K

Property - Plant & Equipment:

$9.50K

Net Tangible Assets:

$-1,562,704

Total Current Assets:

$1M

Net Receivables:

$161.57K

Short-Term Investments:

$10.68K

Accounts Payable:

$1.53M

Non Currrent Assets (Other):

$1.17K

Short-Term Investments:

$10.68

Non Current Liabilities Total:

$0

RSH Share Price History

RSH News

20 May, 2020
Taking the occasional loss comes part and parcel with investing on the stock market. Anyone who held Respiri Limited...
22 Nov, 2019
By buying an index fund, investors can approximate the average market return. But many of us dare to dream of bigger...